Experts call for independent commission separate from FDA to review Covid-19 vaccines

Kathryn Stephenson, MD, MPH (Center for Virology & Vaccine Research, BIDMC) discusses the recent call for the creation of an independent commission separate from the FDA to review data from coronavirus vaccine trials.

The US just topped 6 million coronavirus cases in about 7 months. What happens next is up to you, Birx says

Kathryn Stephenson, MD, MPH (Center for Virology & Vaccine Research, BIDMC) discusses the recent call for the creation of an independent commission separate from the FDA to review data from coronavirus vaccine trials.

For some, COVID-19 symptoms linger for months

Known as “long-haulers,” these patients call for more research, especially in the Boston area.

The Psychiatrist Will See You Online Now

John Torous, MD (Psychiatry, BIDMC) discusses the rise of digital medicine during the COVID-19 pandemic.

Study by Boston researchers shows racial disparities among COVID-19 cases

Researchers at BIDMC and Harvard TH Chan School of Public Health quantified COVID-19′s disproportionate toll on Black and Latinx communities in Massachusetts and explored the extent to which other demographic factors explain racial and ethnic gaps.

New study confirms staggering racial disparities in COVID-19 cases in Massachusetts

The pandemic produced a ’perfect storm’ of factors for communities of color.

Second surge checklist: What Massachusetts still needs to fight another coronavirus wave

Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) and other healthcare professionals put together a checklist of what Massachusetts still needs to prepare for a potential second surge of COVID-19 cases.

Preparations for second surge of coronavirus underway

Alexa B. Kimball, MD, MPH (President & CEO, Harvard Medical Faculty Physicians at BIDMC) discusses how hospitals are preparing for a potential second surge of COVID-19, and why colder months present more of a challenge in terms of social distancing.

Four scenarios on how we might develop immunity to Covid-19

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses how we might develop immunity to COVID-19, noting that it would take time.

1st documented COVID-19 reinfection isn’t surprising, but may offer important clues about virus, experts say

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the first documented case of COVID-19 reinfection.

Some medical professionals skeptical of convalescent plasma to treat COVID-19

C. Michael Gibson (Cardiology, BIDMC) discusses the FDA issuing an emergency use authorization of convalescent plasma for the treatment of COVID-19.

Government funding ‘very important’ to coronavirus vaccine development: Top Harvard scientist

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses “Operation Warp Speed” which has allocated nearly $11 billion to pharmaceutical companies to accelerate the discovery and production of a COVID-19 vaccine.

Russia Vaccine Roll-Out Plan Prompts Virus Mutation Worries

Russia's plan to roll-out a COVID-19 vaccine before full trial results is prompting concern among virus experts, who warn a partially effective shot may encourage the novel coronavirus to mutate. Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) notes that mutation rates for COVID-19 are far lower than viruses like HIV, but there are downsides to using a vaccine that doesn’t work.

COVID-19 disrupted health care for other serious conditions. Now, physicians worry about the long-term consequences

As patients avoided hospitals and doctors’ offices, conditions like cancer and heart disease went untreated. Health care providers now stress the importance of non-COVID-19 care as the pandemic stretches on.

Coronavirus vaccine ‘possible’ by winter: Top Harvard scientist

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the timeline and process of developing a vaccine.

Fireside Chat: Kevin Tabb, MD

Kevin Tabb, MD (CEO & President, BILH) participated in the “Fireside Chat” podcast with Gary Bisbee to discuss Beth Israel Lahey Health, the impact that COVID-19 has had on telehealth services, and leading a health system during a crisis.

New Zealand’s renewed COVID crisis: Why scientists say the virus is hard to contain

Dan Barouch, MD, PhD (Center for Virology and Vaccine Research, BIDMC) discusses the COVID-19 outbreak in New Zealand and why cases are so hard to detect due to asymptomatic cases and spread.

U.S. to make coronavirus strain for possible human challenge trials

But many scientists consider human challenge trials with the coronavirus unethical because there are no "rescue therapies" for those who fall ill.

Coronavirus Might Worsen The College Mental Health Crisis: Can Apps Help?

John Torous, MD (Psychiatry, BIDMC) and colleagues report in Psychiatric Services that college students waiting for mental health services are often directed off-campus or to mobile apps for care.

ABC News Prime: Vaccine Watch

Dan Barouch, MD, PhD (Center for Virology and Va...